Department of Health and Human Services March 13, 2006 – Federal Register Recent Federal Regulation Documents

Proposed Collection; Comment Request; Outcome Evaluation of NCI's Activities To Promote Research Collaboration (APRC) Program
Document Number: E6-3537
Type: Notice
Date: 2006-03-13
Agency: Department of Health and Human Services, National Institutes of Health
In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute (NCI), the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Immunology and Microbiology Devices; Reclassification of Herpes Simplex Virus (Types 1 and/or 2) Serological Assays; Correction
Document Number: E6-3522
Type: Proposed Rule
Date: 2006-03-13
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration is correcting a proposed rule that appeared in the Federal Register of January 9, 2006 (71 FR 1399). That document proposed the reclassification of herpes simplex virus (types 1 and/or 2) serological assays from class III (premarket approval) to class II (special controls). That document inadvertently included a list of references related to a draft guidance that also was announced in the Federal Register of January 9, 2006 (71 FR 1432). The draft guidance contains the correct list of references. This document corrects the error.
Food Additives Permitted For Direct Addition to Food for Human Consumption; Glycerides and Polyglycides
Document Number: 06-2354
Type: Rule
Date: 2006-03-13
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the food additive regulations to provide for the safe use of a mixture of glycerides and polyethylene glycol mono- and di-esters of fatty acids of hydrogenated vegetable oils as an excipient in dietary supplement tablets, capsules, and liquid formulations that are intended for ingestion in daily quantities measured in drops or similar small units of measure. This action is in response to a petition filed by Gattefosse Corp.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.